Top Markets
Coin of the day
Delta-Fly Pharma, Inc. Delta-Fly Pharma, Inc.

Delta-Fly Pharma, Inc.

4598
Classement en actions #32530
Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a... Delta-Fly Pharma, Inc., established in Tokushima, Japan, in 2010, is a biotechnology company focused on the development of innovative oncology drugs. Their comprehensive pipeline includes several drug candidates targeting various cancers. DFP-10917 is currently undergoing Phase III clinical evaluation in the United States and Phase I in Japan for relapsed/refractory acute myeloid leukemia. Another significant compound, DFP-14323, is in Phase III trials for lung cancer. The firm is also advancing DFP-17729 through Phase I/II studies for solid tumors. Furthermore, DFP-11207 has successfully completed its Phase I clinical trial for pancreatic cancer. For hematologic malignancies, DFP-14927 is in Phase I, while DFP-10825 is in preclinical development, targeting gastric and ovarian cancers.
Prix de l'action
$0.69158324
Capitalisation boursière
$9.84M
Changement (1 jour)
0.00%
Changement (1 an)
-84.15%
Pays
JP
Échange Delta-Fly Pharma, Inc. (4598)

Catégorie

Historique des divisions d’actions pour Delta-Fly Pharma, Inc. (4598)
L’action Delta-Fly Pharma, Inc. (symbole : 4598) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 17, 2026.
Une action 4598 achetée avant le Aug 17, 2026 équivaudrait aujourd’hui à 0 actions 4598.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE